NF-κB signaling modulation by EBV and KSHV

Elgui de Oliveira, 2007, DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis, Cancer Lett., 247, 182, 10.1016/j.canlet.2006.05.010 Rappocciolo, 2006, DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages, J. Immunol., 176, 1741, 10.4049/jimmunol.176.3.1741 Wu, 2006, KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo, Blood, 108, 141, 10.1182/blood-2005-04-1697 Cerimele, 2001, Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties, J. Virol., 75, 2435, 10.1128/JVI.75.5.2435-2443.2001 Akula, 2003, Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis, J. Virol., 77, 7978, 10.1128/JVI.77.14.7978-7990.2003 Miller, 2007, Lytic cycle switches of oncogenic human gammaherpesviruses(1), Adv. Cancer Res., 97, 81, 10.1016/S0065-230X(06)97004-3 Brown, 2003, NF-kappaB inhibits gammaherpesvirus lytic replication, J. Virol., 77, 8532, 10.1128/JVI.77.15.8532-8540.2003 Keller, 2006, NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo, Blood, 107, 3295, 10.1182/blood-2005-07-2730 Krug, 2007, Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency, PLoS Pathogens, 3, e11, 10.1371/journal.ppat.0030011 Basseres, 2006, Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression, Oncogene, 25, 6817, 10.1038/sj.onc.1209942 Hayden, 2008, Shared principles in NF-kappaB signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020 Sugano, 1997, Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction, J. Exp. Med., 186, 731, 10.1084/jem.186.5.731 Tolnay, 2002, NF-kappaB regulates the expression of the human complement receptor 2 gene, J. Immunol., 169, 6236, 10.4049/jimmunol.169.11.6236 Ariza, 2009, The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway, J. Immunol., 182, 851, 10.4049/jimmunol.182.2.851 Sadagopan, 2007, Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression, J. Virol., 81, 3949, 10.1128/JVI.02333-06 Sgarbanti, 2004, A requirement for NF-kappaB induction in the production of replication-competent HHV-8 virions, Oncogene, 23, 5770, 10.1038/sj.onc.1207707 Konrad, 2009, A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation, J. Virol., 83, 2563, 10.1128/JVI.01512-08 Izumiya, 2009, NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator, J. Virol., 83, 4435, 10.1128/JVI.01999-08 Guasparri, 2008, EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression, Blood, 111, 3813, 10.1182/blood-2007-03-080309 Matta, 2004, Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP), Proc. Natl. Acad. Sci. U. S. A., 101, 9399, 10.1073/pnas.0308016101 Johansson, 2009, Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression, J. Virol., 83, 1393, 10.1128/JVI.01637-08 Prince, 2003, Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms, J. Virol., 77, 5000, 10.1128/JVI.77.8.5000-5007.2003 Chaudhary, 1999, Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins, Oncogene, 18, 5738, 10.1038/sj.onc.1202976 Guasparri, 2004, KSHV vFLIP is essential for the survival of infected lymphoma cells, J. Exp. Med., 199, 993, 10.1084/jem.20031467 Seo, 2004, Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus, Oncogene, 23, 6146, 10.1038/sj.onc.1207807 Ye, 2008, Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency, J. Virol., 82, 4235, 10.1128/JVI.02370-07 Lei, 2010, Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA, Nat. Cell Biol., 12, 193, 10.1038/ncb2019 Samaniego, 2000, Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?, J. Natl. Cancer Inst. Monogr., 2000, 15, 10.1093/oxfordjournals.jncimonographs.a024252 Prakash, 2002, Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene, J. Natl. Cancer Inst., 94, 926, 10.1093/jnci/94.12.926 Morrison, 2004, BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function, Virology, 328, 219, 10.1016/j.virol.2004.07.020 Cannon, 2004, The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells, Oncogene, 23, 514, 10.1038/sj.onc.1207021 Martin, 2008, An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia, Oncogene, 27, 1844, 10.1038/sj.onc.1210817 Cannon, 2006, KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2, Blood, 107, 277, 10.1182/blood-2005-06-2350 Brinkmann, 2003, Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein, J. Virol., 77, 9346, 10.1128/JVI.77.17.9346-9358.2003 Sharp, 2002, K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function, J. Virol., 76, 802, 10.1128/JVI.76.2.802-816.2002 Grossmann, 2008, Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent, Virology, 375, 94, 10.1016/j.virol.2007.12.044 Glaunsinger, 2004, Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis, J. Exp. Med., 200, 391, 10.1084/jem.20031881 Terrin, 2008, Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes, J. Virol., 82, 10175, 10.1128/JVI.00321-08 Feuillard, 2000, Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes, Blood, 95, 2068, 10.1182/blood.V95.6.2068.2068 Lu, 2008, Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence, J. Virol., 82, 10436, 10.1128/JVI.00752-08 Kung, 2008, Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3, J. Virol., 82, 5486, 10.1128/JVI.00125-08 Nakamura, 2008, The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB, Virus Res., 131, 170, 10.1016/j.virusres.2007.09.003 Dechend, 1999, The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators, Oncogene, 18, 3316, 10.1038/sj.onc.1202717 Thornburg, 2007, Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes, J. Virol., 81, 12954, 10.1128/JVI.01601-07 Westerheide, 2001, The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition, Mol. Cell Biol., 21, 8428, 10.1128/MCB.21.24.8428-8436.2001 Kashatus, 2006, Expression of the Bcl-3 proto-oncogene suppresses p53 activation, Genes Dev., 20, 225, 10.1101/gad.1352206 Dawson, 2001, The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1, Virology, 289, 192, 10.1006/viro.2001.1142 Caselli, 2007, Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-kappaB pathway, Blood, 109, 2718, 10.1182/blood-2006-03-012500 Matta, 2007, Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13, Oncogene, 26, 1656, 10.1038/sj.onc.1209931 Punj, 2009, Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation, Blood, 113, 5660, 10.1182/blood-2008-10-186403 Min, 2008, NF-kappaB and epithelial to mesenchymal transition of cancer, J. Cell Biochem., 104, 733, 10.1002/jcb.21695 Caldwell, 1998, Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals, Immunity, 9, 405, 10.1016/S1074-7613(00)80623-8 Kang, 2005, Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice, Proc. Natl. Acad. Sci. U. S. A., 102, 820, 10.1073/pnas.0408774102 Kang, 2008, Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice, J. Virol., 82, 4180, 10.1128/JVI.02596-07 Shair, 2007, EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas, PLoS Pathogens, 3, e166, 10.1371/journal.ppat.0030166 Chugh, 2005, Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 102, 12885, 10.1073/pnas.0408577102 Belanger, 2001, Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation, J. Hum. Virol., 4, 62 Field, 2003, KSHV vFLIP binds to IKK-gamma to activate IKK, J. Cell Sci., 116, 3721, 10.1242/jcs.00691 Sturzl, 1999, Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells, J. Natl. Cancer Inst., 91, 1725, 10.1093/jnci/91.20.1725 Montaner, 2003, Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes, Cancer Cell, 3, 23, 10.1016/S1535-6108(02)00237-4 Yang, 2000, Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma, J. Exp. Med., 191, 445, 10.1084/jem.191.3.445 Cannon, 2003, The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells, J. Virol., 77, 57, 10.1128/JVI.77.1.57-67.2003 Bais, 1998, G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator, Nature, 391, 86, 10.1038/34193 Mutlu, 2007, In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma, Cancer Cell, 11, 245, 10.1016/j.ccr.2007.01.015 Wang, 2006, Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus, Cancer Res., 66, 3658, 10.1158/0008-5472.CAN-05-3680 Prakash, 2005, Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis, Blood, 105, 3987, 10.1182/blood-2004-07-2781 Lee, 1998, Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus, Nat. Med., 4, 435, 10.1038/nm0498-435 An, 2004, Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas, Leukemia, 18, 1699, 10.1038/sj.leu.2403460 Ghosh, 2003, Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B, Blood, 101, 2321, 10.1182/blood-2002-08-2525 Stumpf, 2002, Herpes viruses hedge their bets, Proc. Natl. Acad. Sci. U. S. A., 99, 15234, 10.1073/pnas.232546899 Thorley-Lawson, 2008, Epstein-Barr virus: a paradigm for persistent infection – for real and in virtual reality, Trends Immunol., 29, 195, 10.1016/j.it.2008.01.006 Gires, 1997, Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule, EMBO J., 16, 6131, 10.1093/emboj/16.20.6131 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1997) Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr. Eval. Carcinog. Risks Hum. 70, 1–492 Cahir McFarland, 1999, Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB, Oncogene, 18, 6959, 10.1038/sj.onc.1203217 Kieser, 2008, Pursuing different ‘TRADDes’: TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1, Biol. Chem., 389, 1261, 10.1515/BC.2008.144 Mainou, 2007, Unique signaling properties of CTAR1 in LMP1-mediated transformation, J. Virol., 81, 9680, 10.1128/JVI.01001-07 Atkinson, 2003, Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52, J. Biol. Chem., 278, 51134, 10.1074/jbc.M304771200 Wang, 1985, An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells, Cell, 43, 831, 10.1016/0092-8674(85)90256-9 Homig-Holzel, 2008, Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis, J. Exp. Med., 205, 1317, 10.1084/jem.20080238 Kulwichit, 1998, Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 95, 11963, 10.1073/pnas.95.20.11963 Panagopoulos, 2004, Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo, J. Virol., 78, 13253, 10.1128/JVI.78.23.13253-13261.2004 Guasparri, 2006, The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling, EMBO Rep., 7, 114, 10.1038/sj.embor.7400580 Matta, 2007, Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation, J. Biol. Chem., 282, 24858, 10.1074/jbc.M700118200 Beisser, 2005, The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase, J. Virol., 79, 441, 10.1128/JVI.79.1.441-449.2005